Literature DB >> 2348440

CPK elevation in the spondyloarthropathies.

A Bohan, J Stracner, S Norton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2348440

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

1.  Decreased serum biochemical markers of muscle origin in patients with ankylosing spondylitis.

Authors:  E J Giltay; D van Schaardenburg; L J Gooren; P J Kostense; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1999-09       Impact factor: 19.103

2.  Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study.

Authors:  R Landewé; J Braun; A Deodhar; M Dougados; W P Maksymowych; P J Mease; J D Reveille; M Rudwaleit; D van der Heijde; C Stach; B Hoepken; A Fichtner; G Coteur; M de Longueville; J Sieper
Journal:  Ann Rheum Dis       Date:  2013-09-06       Impact factor: 19.103

Review 3.  Muscle Evaluation in Axial Spondyloarthritis-The Evidence for Sarcopenia.

Authors:  Ana Valido; Carolina Lage Crespo; Fernando M Pimentel-Santos
Journal:  Front Med (Lausanne)       Date:  2019-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.